NIPRO DIAGNOSTICS, INC.
Manufacturer adverse-event records for NIPRO DIAGNOSTICS, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2010–2017 · thin-book · typical Death-code · injury-light
Injury-mix signature
NIPRO DIAGNOSTICS, INC. is lighter on Injury codes
Injury-coded event_type share is 0.1% (injury-light tercile) beside 0.20% Death-coded (typical). Volume band: thin.
What the Injury-mix reading shows for NIPRO DIAGNOSTICS, INC.
The standout signal for NIPRO DIAGNOSTICS, INC. is Injury-mix: 0.1% Injury-coded (injury-light) beside 0.20% Death-coded, on a thin-book footprint.
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 6 device types, led in this extract by Malfunction at 3,955 (99.4% of event_type total). Peak single-year volume reaches 2,430 reports across 8 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (6)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.